Hormone replacement therapy: a survey of Ontario physicians' prescribing practices

• Published in: Canadian Medical Association journal (CMAJ) Vol. 161; no. 6; pp. 695 - 698
• Main Authors: Elinson, L, Cohen, M M, Elmslie, T
• Format: Journal Article
• Language: English
• Published: Canada CMA Impact, Inc 21.09.1999
• Subjects: Adult; Attitude of Health Personnel; Evidence; Female; Guideline Adherence; Health Care Surveys; Hormone replacement therapy; Hormone Replacement Therapy - utilization; Humans; Male; Middle Aged; Nursing; Ontario; Physicians; Polls & surveys; Postmenopause; Practice Patterns, Physicians' - statistics & numerical data; Prescriptions; Ontario; Ontario Canada; Canada
• ISSN: 0820-3946; 1488-2329

Although much has been written about hormone replacement therapy (HRT), there are few clearcut recommendations on its use. The purpose of this study was to determine Ontario physicians' patterns of and reasons for prescribing HRT, their use of pretreatment investigations and their surveillance of HRT users, and to determine whether physicians' reported practice is consistent with existing recommendations. A self-administered questionnaire was mailed to a nonproportional stratified sample of 327 Ontario physicians (23.9% gynecologists, 76.1% general practitioners/family physicians [GP/FPs]). Outcome measures were ranking of reasons for prescribing HRT, nature of preliminary testing, regimens prescribed, duration of HRT and frequency of follow-up. The response rate was 60.9% overall (70.9% of the gynecologists, 58.3% of the GP/FPs). Prevention of osteoporosis was reported by 97.4% as an important or very important reason for prescribing HRT; prevention of coronary artery disease was important or very important for 89.3%. When considering whether or not to prescribe HRT, 97.3% stated that breast cancer was an important or very important factor. When presented with hypothetical cases, 97.0% stated that they would prescribe combined estrogen-progestin for a symptomatic woman with an intact uterus; 13.6% stated that they would do so for a woman with no uterus. Most reported that they would prescribe HRT for 12 or more years (73.3%) and would follow up patients every 1 to 2 years (70.6%). Despite controversy about HRT in the published literature, the Ontario physicians surveyed reported similar reasons and patterns of prescribing, pretreatment investigations, and surveillance of postmenopausal women using HRT. These results suggest that Ontario physicians' knowledge about HRT is consistent with recommendations in the published literature.